Provided by Tiger Fintech (Singapore) Pte. Ltd.

Ventyx Biosciences, Inc.

1.16
-0.0200-1.69%
Post-market: 1.160.00000.00%16:19 EDT
Volume:855.93K
Turnover:999.61K
Market Cap:82.51M
PE:-0.59
High:1.22
Open:1.22
Low:1.14
Close:1.18
Loading ...
Jan 03, 2024

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Dec 21, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 21, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 21, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 07, 2023

Major Issues Report

Form 8-K - Current report
Nov 22, 2023

Major Issues Report

Form 8-K - Current report
Nov 09, 2023

Major Issues Report

Form 8-K - Current report
Nov 09, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 07, 2023

Major Issues Report

Form 8-K - Current report
Oct 10, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Oct 10, 2023

Major Issues Report

Form 8-K - Current report
Oct 06, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Oct 03, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Oct 03, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Sep 05, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Sep 05, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Sep 05, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Sep 05, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 31, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 11, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]